Billinghurst R Clark, Brama Pieter A J, van Weeren P Rene, Knowlton Megan S, McIlwraith C Wayne
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Am J Vet Res. 2004 Feb;65(2):143-50. doi: 10.2460/ajvr.2004.65.143.
To determine whether serum concentrations of biomarkers of skeletal metabolism can, in conjunction with radiographic evaluation, indicate severity of osteochondrosis in developing horses.
43 Dutch Warmblood foals with varying severity of osteochondrosis.
24 foals were monitored for 5 months and 19 foals were monitored for 11 months. Monthly radiographs of femoropatellar-femorotibial and tibio-tarsal joints were graded for osteochondral abnormalities. Serial blood samples were assayed for 8 cartilage and bone biomarkers. At the end of the monitoring period, foals were examined for macroscopic osteochondrosis lesions.
Temporal relationships were evident between certain serum biomarkers and osteochondrosis severity in foals during their first year. Biomarkers of collagen degradation (collagenase-generated neoepitopes of type-II collagen fragments, type-I and -II collagen fragments [COL2-3/4C(short)], and cross-linked telopeptide fragments of type-I collagen) and bone mineralization (osteocalcin) were positive indicators of osteochondrosis severity at 5 months of age. In foals with lesions at 11 months of age, osteochondrosis severity correlated negatively with COL2-3/4C(short) and osteocalcin and positively with C-propeptide of type-II procollagen (CPII), a collagen synthesis marker. Radiographic grading of osteochondrosis lesions significantly correlated with macroscopic osteochondrosis severity score at both ages and was strongest when combined with osteocalcin at 5 months and CPII at 11 months.
The ability of serum biomarkers to indicate osteochondrosis severity appears to depend on stage of disease and is strengthened with radiography. In older foals with more permanent lesions, osteochondrosis severity is significantly related to biomarker concentrations of decreased bone formation and increased cartilage synthesis.
确定骨骼代谢生物标志物的血清浓度是否能与影像学评估相结合,指示发育中马匹骨软骨病的严重程度。
43匹患有不同严重程度骨软骨病的荷兰温血马驹。
对24匹马驹进行5个月的监测,对19匹马驹进行11个月的监测。每月对股髌-股胫和胫跗关节进行X线摄影,对骨软骨异常进行分级。对系列血样检测8种软骨和骨生物标志物。在监测期结束时,对马驹进行宏观骨软骨病病变检查。
在马驹出生后的第一年,某些血清生物标志物与骨软骨病严重程度之间存在明显的时间关系。胶原蛋白降解生物标志物(II型胶原蛋白片段的胶原酶产生的新表位、I型和II型胶原蛋白片段[COL2-3/4C(短链)]以及I型胶原蛋白的交联端肽片段)和骨矿化生物标志物(骨钙素)是5月龄时骨软骨病严重程度的阳性指标。在11月龄有病变的马驹中,骨软骨病严重程度与COL2-3/4C(短链)和骨钙素呈负相关,与II型前胶原的C-前肽(CPII,一种胶原蛋白合成标志物)呈正相关。骨软骨病病变的X线摄影分级在两个年龄阶段均与宏观骨软骨病严重程度评分显著相关,在5月龄时与骨钙素结合以及在11月龄时与CPII结合时相关性最强。
血清生物标志物指示骨软骨病严重程度的能力似乎取决于疾病阶段,并且通过影像学检查可得到增强。在患有更永久性病变的大龄马驹中,骨软骨病严重程度与骨形成减少和软骨合成增加的生物标志物浓度显著相关。